Vouliez-vous dire
level vaccines indicates

Résultats de la recherche - 11 results

QuilA-Adjuvanted T. gondii Lysate Antigens Trigger Robust Antibody and IFNγ+ T Cell Responses in Pigs Leading to Reduction in Parasite DNA in Tissues Upon Challenge InfectionImage

scarce, vaccination of meat producing animals may prevent T. gondii transmission to humans. Here, we evaluated the elicited immune responses and the efficacy of a potential vaccine candidate, generated by ...

Pre-registration efficacy study of a novel marker vaccine against classical swine fever on maternally derived antibody positive (MDA+) target animals.

efficacy of live attenuated vaccines against classical swine fever (CSF). For this reason, a marker vaccine candidate CP7_E2alf was tested for its efficacy in the presence of MDA. Pregnant sows were ...

Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli.

, Synthetic Vaccines, Virus-Like Particle Veterinary Medicine Viral Matrix Proteins Abstract: Virus-like particles (VLP s) are promising molecular structures for the design and construction of novel vaccines ...

Pre-registration efficacy study of a novel marker vaccine against classical swine fever on Maternally Derived Antibody negative (MDA-) target animals.

The level of protection was determined by the development of clinical signs, viraemia and rate of mortality. The vaccine candidate met the criteria of Ph. Eur Monograph 0065, “Swine-fever vaccine (live, ...

DNA vaccines against tuberculosis.

remains a major health problem and novel vaccination regimens are urgently needed. AREAS COVERED: DNA vaccines against TB have been tested in various preclinical models and strategies have been developed to ...

Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations.

Issue 2, p.463-99 (2014) Abstract: Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidity and mortality worldwide. Several TB vaccine candidates are currently in ...

An update on vaccines for tuberculosis- there is more to it than just waning of BCG efficacy with time.

update on the ongoing Phase I and Phase II clinical trials is given. Finally, some of the most promising novel pre-clinical developments using live attenuated vaccines, sub-unit vaccines, prime-boost ...

Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.

Mycobacterium tuberculosis Th1 Cells Tuberculosis Tuberculosis Vaccines Vaccines, DNA Abstract: Novel vaccines are needed to control tuberculosis (TB), the bacterial infectious disease that together with malaria ...

Immunogenicity and protective efficacy of DNA vaccines encoding MAP0586c and MAP4308c of Mycobacterium avium subsp. paratuberculosis secretome.

extent as the Mycobacterium bovis BCG vaccine, indicating that this putative transglycosylase is an interesting vaccine candidate that warrants further investigation. Health Topics:  Health and disease ...

QR code

QR code for this page URL